7CNM
YDX in complex with tubulin
Summary for 7CNM
Entry DOI | 10.2210/pdb7cnm/pdb |
Descriptor | Tubulin alpha-1B chain, (2~{S},4~{S})-4-[[2-[(1~{R},3~{R})-1-acetyloxy-4-methyl-3-[[(2~{S},3~{S})-3-methyl-2-[[(2~{R})-1-methylpiperidin-2-yl]carbonylamino]pentanoyl]amino]pentyl]-1,3-thiazol-4-yl]carbonylamino]-5-cyclohexyl-2-methyl-pentanoic acid, PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER, ... (12 entities in total) |
Functional Keywords | ydx, tubulin, protein-drug complex, cell cycle |
Biological source | Mus musculus (Mouse) More |
Total number of polymer chains | 6 |
Total formula weight | 266248.02 |
Authors | Wang, Y.X.,Wu, C.Y. (deposition date: 2020-08-02, release date: 2021-08-04, Last modification date: 2023-11-29) |
Primary citation | Chengyong, W.,Jinghong, X.,Yanyan, W.,Qing-Jie, X.,Lingling, M.,Yuyan, L.,Hai, C.,Qian, L.,Quan, Z.,Bo, S.,Yuxi, W. The high-resolution X-ray structure of vinca-domain inhibitors of microtubules provides a rational approach for drug design. Febs Lett., 595:195-205, 2021 Cited by PubMed: 33220079DOI: 10.1002/1873-3468.14003 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.44 Å) |
Structure validation
Download full validation report